Search research articles
Contact Us
Filters
Showing results (521-530 of 643) with videos related to
Page
of 65
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)
Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
Investigational New Drugs
|
November 22, 2017
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
Takeo Fujii, Rivka R Colen, Mehmet Asim Bilen, et al.
JAMA Oncology
|
November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab
Reva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
British Journal of Cancer
|
April 27, 2018
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers
Shiraj Sen, Shumei Kato, Rishi Agarwal, et al.
Cancers
|
October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer
Timothy P DiPeri, Kurt W Evans, Stephen Scott, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
Ji Son, Heather Y Lin, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Clinical Proteomics
|
June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
Bryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Clinical Proteomics
|
September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Ana M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Page
of 65
Search research articles
Search
Showing results (521-530 of 643) with videos related to
Sort By:
Page
of 65
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)
Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
Investigational New Drugs
|
November 22, 2017
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
Takeo Fujii, Rivka R Colen, Mehmet Asim Bilen, et al.
JAMA Oncology
|
November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab
Reva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
British Journal of Cancer
|
April 27, 2018
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers
Shiraj Sen, Shumei Kato, Rishi Agarwal, et al.
Cancers
|
October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer
Timothy P DiPeri, Kurt W Evans, Stephen Scott, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
Ji Son, Heather Y Lin, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Clinical Proteomics
|
June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
Bryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Clinical Proteomics
|
September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Ana M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Page
of 65